Every year, on 28 July, the WHO and its partners mark World Hepatitis Day to raise awareness and understanding of viral hepatitis and the diseases it causes. This day is an opportunity to boost national and international efforts to defeat hepatitis, inspire actions and engagement from individuals, partners, and the public, and emphasize the need for a more robust global response.
Drug discovery has played a crucial role in developing antiviral drugs to cure hepatitis C, a leading cause of liver cancer and cirrhosis. These drugs have transformed the treatment landscape, allowing many people living with hepatitis C to be cured with just a few weeks of medication. However, more research is needed to develop effective treatments for hepatitis B, which still affects over 250 million people globally.
To support anti-hepatitis drug discovery globally, Life Chemicals is offering its dedicated Anti-hepatitis Screening Libraries, along with a collection of related screening libraries for hepatitis-related targets:
- Antiviral Libraries
- Helicase Focused Library
- Serine Protease Focused Library
- Protein-Protein Interactions (PPI) Screening Libraries: Ligand-Based Approach
Please, contact us at marketing@lifechemicals.com for any additional information and price quotations.
Download SD files with compound structures directly from our Downloads section
Custom compound selection based on specific parameters can be performed on request.
Competitive pricing and the most convenient terms are provided.